
Shahid R. Merchant
Supervisory Patent Examiner (ID: 2793, Phone: (571)270-1360 , Office: P/3693 )
| Most Active Art Unit | 3694 |
| Art Unit(s) | 3694, 3626, 3692, 3684, 3693 |
| Total Applications | 227 |
| Issued Applications | 52 |
| Pending Applications | 22 |
| Abandoned Applications | 153 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17546634
[patent_doc_number] => 20220117975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF DEPRESSION AND OTHER DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/431422
[patent_app_country] => US
[patent_app_date] => 2020-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37081
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17431422
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/431422 | Compositions and methods for treatment of depression and other disorders | Feb 17, 2020 | Issued |
Array
(
[id] => 17896974
[patent_doc_number] => 20220306636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED JAK INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/428850
[patent_app_country] => US
[patent_app_date] => 2020-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28289
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428850
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/428850 | Process for preparing enantiomerically enriched JAK inhibitors | Feb 5, 2020 | Issued |
Array
(
[id] => 17473918
[patent_doc_number] => 20220081422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => DIHYDROOROTATE DEHYDROGENASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/428997
[patent_app_country] => US
[patent_app_date] => 2020-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39425
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428997
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/428997 | DIHYDROOROTATE DEHYDROGENASE INHIBITORS | Feb 5, 2020 | Abandoned |
Array
(
[id] => 17561635
[patent_doc_number] => 20220125784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => METHODS AND COMPOUNDS FOR INHIBITION OF INACTIVATION OF VOLTAGE-GATED SODIUM CHANNELS
[patent_app_type] => utility
[patent_app_number] => 17/427949
[patent_app_country] => US
[patent_app_date] => 2020-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13547
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17427949
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/427949 | METHODS AND COMPOUNDS FOR INHIBITION OF INACTIVATION OF VOLTAGE-GATED SODIUM CHANNELS | Feb 3, 2020 | Pending |
Array
(
[id] => 17577102
[patent_doc_number] => 20220133957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => Sclerostin Inhibitors That Promote Bone Morphogenetic Protein Expression
[patent_app_type] => utility
[patent_app_number] => 17/428556
[patent_app_country] => US
[patent_app_date] => 2020-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12968
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428556
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/428556 | Sclerostin Inhibitors That Promote Bone Morphogenetic Protein Expression | Feb 3, 2020 | Abandoned |
Array
(
[id] => 17503371
[patent_doc_number] => 20220096473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => METHOD FOR TREATING AN ACUTE MYELOID LEUKEMIA
[patent_app_type] => utility
[patent_app_number] => 17/421832
[patent_app_country] => US
[patent_app_date] => 2020-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14925
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17421832
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/421832 | METHOD FOR TREATING AN ACUTE MYELOID LEUKEMIA | Jan 14, 2020 | Abandoned |
Array
(
[id] => 17503401
[patent_doc_number] => 20220096503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => COMBINATION PHARMACEUTICAL COMPOSITIONS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/422074
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11423
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17422074
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/422074 | COMBINATION PHARMACEUTICAL COMPOSITIONS AND METHODS THEREOF | Jan 9, 2020 | Pending |
Array
(
[id] => 17519234
[patent_doc_number] => 20220105082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => NEW FORMULATIONS CONTAINING LEUKOTRIENE RECEPTOR ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 17/421867
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14244
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -45
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17421867
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/421867 | NEW FORMULATIONS CONTAINING LEUKOTRIENE RECEPTOR ANTAGONISTS | Jan 9, 2020 | Abandoned |
Array
(
[id] => 17578722
[patent_doc_number] => 20220135577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => DIHYDROPYRAZOLOPYRAZINONE DERIVATIVE HAVING MGAT2 INHIBITORY
ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/422108
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25912
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17422108
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/422108 | Dihydropyrazolopyrazinone derivative having MGAT2 inhibitory activity | Jan 9, 2020 | Issued |
Array
(
[id] => 17441774
[patent_doc_number] => 20220062279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => TREATMENT OF MOVEMENT DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/415236
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9976
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17415236
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/415236 | TREATMENT OF MOVEMENT DISORDERS | Dec 19, 2019 | Abandoned |
Array
(
[id] => 17368142
[patent_doc_number] => 20220023194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => Cosmetic Mask Comprising a Plant Paper and Humectant
[patent_app_type] => utility
[patent_app_number] => 17/296693
[patent_app_country] => US
[patent_app_date] => 2019-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5642
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17296693
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/296693 | Cosmetic Mask Comprising a Plant Paper and Humectant | Nov 25, 2019 | Pending |
Array
(
[id] => 18194386
[patent_doc_number] => 20230047905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/294965
[patent_app_country] => US
[patent_app_date] => 2019-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45974
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -351
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17294965
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/294965 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | Nov 18, 2019 | Abandoned |
Array
(
[id] => 19608875
[patent_doc_number] => 12157741
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-03
[patent_title] => Macrocyclic inhibitors of DYRK1A
[patent_app_type] => utility
[patent_app_number] => 17/293292
[patent_app_country] => US
[patent_app_date] => 2019-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25726
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 306
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293292
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/293292 | Macrocyclic inhibitors of DYRK1A | Nov 18, 2019 | Issued |
Array
(
[id] => 17561640
[patent_doc_number] => 20220125789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => PHARMACEUTICAL PREPARATION OF FRUQUINTINIB AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/293790
[patent_app_country] => US
[patent_app_date] => 2019-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3054
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293790
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/293790 | PHARMACEUTICAL PREPARATION OF FRUQUINTINIB AND USE THEREOF | Nov 14, 2019 | Pending |
Array
(
[id] => 17342088
[patent_doc_number] => 20220008419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => PHARMACEUTICAL COMPOSITION FOR TREATING DIFFUSE-TYPE GASTRIC CANCER
[patent_app_type] => utility
[patent_app_number] => 17/293114
[patent_app_country] => US
[patent_app_date] => 2019-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9317
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293114
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/293114 | PHARMACEUTICAL COMPOSITION FOR TREATING DIFFUSE-TYPE GASTRIC CANCER | Nov 13, 2019 | Abandoned |
Array
(
[id] => 17342061
[patent_doc_number] => 20220008392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => METHODS OF TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/293155
[patent_app_country] => US
[patent_app_date] => 2019-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4064
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293155
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/293155 | METHODS OF TREATING CANCER | Nov 12, 2019 | Abandoned |
Array
(
[id] => 17368111
[patent_doc_number] => 20220023163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => COMPOSITION COMPRISING TWO POLYGLYCERYL FATTY ACID ESTERS
[patent_app_type] => utility
[patent_app_number] => 17/296955
[patent_app_country] => US
[patent_app_date] => 2019-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17296955
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/296955 | COMPOSITION COMPRISING TWO POLYGLYCERYL FATTY ACID ESTERS | Nov 5, 2019 | Pending |
Array
(
[id] => 17334702
[patent_doc_number] => 20220001033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => PHOSPHATE COMPOUNDS FOR DETECTING NEUROLOGICAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/290727
[patent_app_country] => US
[patent_app_date] => 2019-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19213
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17290727
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/290727 | PHOSPHATE COMPOUNDS FOR DETECTING NEUROLOGICAL DISORDERS | Oct 31, 2019 | Abandoned |
Array
(
[id] => 17212985
[patent_doc_number] => 20210346321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => PHARMACEUTICAL COMPOSITION CONTAINING ALKYL CARBAMOYL NAPHTHALENYLOXY OCTENOYL HYDROXYAMIDE PHOSPHATE, TARTRATE OR COMBINATION THEREOF, AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/283627
[patent_app_country] => US
[patent_app_date] => 2019-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17283627
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/283627 | PHARMACEUTICAL COMPOSITION CONTAINING ALKYL CARBAMOYL NAPHTHALENYLOXY OCTENOYL HYDROXYAMIDE PHOSPHATE, TARTRATE OR COMBINATION THEREOF, AND PREPARATION METHOD THEREFOR | Oct 27, 2019 | Pending |
Array
(
[id] => 17290806
[patent_doc_number] => 20210386645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => TOPICAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/283111
[patent_app_country] => US
[patent_app_date] => 2019-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3757
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17283111
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/283111 | TOPICAL COMPOSITIONS | Oct 3, 2019 | Abandoned |